RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,221,664 | +91.4% | 2,057,096 | +128.6% | 0.00% | +200.0% |
| Q2 2023 | $1,160,798 | -34.8% | 899,843 | -33.3% | 0.00% | -50.0% |
| Q1 2023 | $1,779,667 | -60.4% | 1,348,232 | -55.0% | 0.00% | -66.7% |
| Q4 2022 | $4,497,738 | +6.0% | 2,998,491 | -16.7% | 0.01% | 0.0% |
| Q3 2022 | $4,245,151 | +3216.5% | 3,597,586 | +3096.4% | 0.01% | – |
| Q2 2022 | $128,000 | -42.3% | 112,550 | +51.4% | 0.00% | – |
| Q1 2022 | $222,000 | +24.0% | 74,329 | +9.9% | 0.00% | – |
| Q4 2021 | $179,000 | -29.5% | 67,664 | -3.6% | 0.00% | -100.0% |
| Q3 2021 | $254,000 | -15.9% | 70,216 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $302,000 | +14.0% | 69,531 | -10.2% | 0.00% | 0.0% |
| Q1 2021 | $265,000 | +1.9% | 77,397 | +4.3% | 0.00% | 0.0% |
| Q4 2020 | $260,000 | +73.3% | 74,193 | +18.5% | 0.00% | – |
| Q3 2020 | $150,000 | +30.4% | 62,586 | 0.0% | 0.00% | – |
| Q2 2020 | $115,000 | -13.5% | 62,586 | -26.9% | 0.00% | – |
| Q1 2020 | $133,000 | -27.3% | 85,562 | 0.0% | 0.00% | – |
| Q4 2019 | $183,000 | +30.7% | 85,562 | +14.1% | 0.00% | – |
| Q3 2019 | $140,000 | -28.6% | 74,982 | 0.0% | 0.00% | – |
| Q2 2019 | $196,000 | +11.4% | 74,982 | +9.2% | 0.00% | – |
| Q1 2019 | $176,000 | +11.4% | 68,668 | 0.0% | 0.00% | – |
| Q4 2018 | $158,000 | -28.2% | 68,668 | 0.0% | 0.00% | – |
| Q3 2018 | $220,000 | +13.4% | 68,668 | 0.0% | 0.00% | – |
| Q2 2018 | $194,000 | -14.9% | 68,668 | +6.6% | 0.00% | – |
| Q1 2018 | $228,000 | -8.8% | 64,417 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $250,000 | +83.8% | 64,417 | +20.0% | 0.00% | – |
| Q3 2017 | $136,000 | -6.8% | 53,661 | 0.0% | 0.00% | – |
| Q2 2017 | $146,000 | +7.4% | 53,661 | +30.4% | 0.00% | – |
| Q1 2017 | $136,000 | +38.8% | 41,161 | 0.0% | 0.00% | – |
| Q4 2016 | $98,000 | -35.1% | 41,161 | 0.0% | 0.00% | – |
| Q3 2016 | $151,000 | +64.1% | 41,161 | 0.0% | 0.00% | – |
| Q2 2016 | $92,000 | +7.0% | 41,161 | 0.0% | 0.00% | – |
| Q1 2016 | $86,000 | -31.2% | 41,161 | 0.0% | 0.00% | – |
| Q4 2015 | $125,000 | +22.5% | 41,161 | 0.0% | 0.00% | – |
| Q3 2015 | $102,000 | -46.0% | 41,161 | -30.2% | 0.00% | – |
| Q2 2015 | $189,000 | -21.9% | 59,007 | -13.0% | 0.00% | -100.0% |
| Q1 2015 | $242,000 | +12.6% | 67,830 | -28.3% | 0.00% | – |
| Q4 2014 | $215,000 | +17.5% | 94,546 | -0.0% | 0.00% | – |
| Q3 2014 | $183,000 | -46.6% | 94,565 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $343,000 | -6.5% | 94,565 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $367,000 | +35.9% | 94,565 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $270,000 | -20.4% | 94,565 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $339,000 | +7.3% | 94,565 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $316,000 | – | 94,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |